-+ 0.00%
-+ 0.00%
-+ 0.00%

ACTUATE THERAPEUTICS REPORTS POSITIVE MONOTHERAPY DATA IN AGGRESSIVE MELANOMA PRECLINICAL MODEL WITH DAILY DOSING OF ELRAGLUSIB ORAL TABLET AT ENA 2026

Reuters·11/18/2026 13:00:03

Please log in to view news